Enhanced drug efflux caused by ATP-binding cassette (ABC) transporters is an important contributor of drug resistance. Up-regulated lncRNA NR2F1-AS1 confers HCC resistance to oxaliplatin by targeting ABCC122. This evidence concerns the gene NR2F1 and hepatocellular carcinoma.